Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | F9 | P00740 | 1/20 | 0.38 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.36 |
| ▸ | TNKS | O95271 | 1/20 | 0.35 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.35 |
| ▸ | GPR3 | P46089 | 1/20 | 0.34 |
| ▸ | LIMK1 | P53667 | 3/20 | 0.33 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 2/20 | 0.32 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24472257 | 0.96 | ALOX5 (0.45) | ALOX5F9PARP14TNKSTNKS2 | |
| SCHEMBL21168545 | 0.96 | ALOX5 (0.45) | ALOX5F9PARP14TNKSTNKS2 | |
| SCHEMBL18212087 | 0.95 | ALOX5 (0.50) | ALOX5F9PARP14TNKSTNKS2 | |
| SCHEMBL24472470 | 0.95 | ALOX5 (0.44) | ALOX5F9PARP14TNKSTNKS2 | |
| SCHEMBL21214776 | 0.94 | ALOX5 (0.46) | ALOX5F9PARP14TNKSTNKS2 | |
| SCHEMBL24370265 | 0.93 | ALOX5 (0.43) | ALOX5F9PARP14TNKSTNKS2 | |
| SCHEMBL24370078 | 0.93 | ALOX5 (0.43) | ALOX5F9PARP14TNKSTNKS2 | |
| SCHEMBL15964352 | 0.93 | ALOX5 (0.42) | ALOX5F9PARP14TNKSTNKS2 | |
| SCHEMBL15964350 | 0.93 | ALOX5 (0.42) | ALOX5F9PARP14TNKSTNKS2 | |
| SCHEMBL22255465 | 0.93 | ALOX5 (0.41) | ALOX5F9PARP14TNKSTNKS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230172060-A1 | ORGANIC LIGHT EMITTING DEVICE | LG DISPLAY CO LTD (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20230172060-A1 | ORGANIC LIGHT EMITTING DEVICE | LG DISPLAY CO LTD (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20200203619-A1 | ORGANIC LIGHT EMITTING DEVICE | LG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203619-A1 | ORGANIC LIGHT EMITTING DEVICE | MAP1LC3A, MAP1LC3C, MAP1LC3B | ALOX5 1081/4885F9 3650/4885PARP14 1146/4885 |
| US-20230172060-A1 | ORGANIC LIGHT EMITTING DEVICE | MAP1LC3A, MAP1LC3C, MAP1LC3B | ALOX5 1081/4885F9 3650/4885PARP14 1146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.